… antibodies … lipase (LPL), a key enzyme that hydrolyzes triglycerides, suggests a role of
autoimmunity for elevated serum triglyceride levels and atherosclerosis in patients with systemic …

… [1] concerning lipid-profile abnormalities in patients with limited systemic sclerosis. The paper
… However, in the light of our study, scleroderma itself minimized the influence of the thyroid …

… Systemic sclerosis (SSc) is characterized by peripheral … , α2AP can bind and activate adipose
triglyceride lipase (ATGL) [5], … d Paraffin sections were stained with α-SMA antibodies. e …

Este artigo tem como objetivo revisar os aspectos descritos na literatura sobre o acometimento
da macrovasculatura na esclerose sistêmica e avaliar a ocorrência e distribuição das …

… bind and activate adipose triglyceride lipase (ATGL), which is … anti-centromere antibodies
and anti-Scl70 antibodies in SSc … α2AP neutralizing antibodies attenuates anti-Scl70 antibody …

… able to differentiate into adipocytes expressing lipoprotein lipase (Lpl), peroxisome proliferator-…
However, in this setting, we did not observe a reduction of anti-scl70 antibody production (…

… antibodies and to determine, quantitatively, the expression level of p53 and TBP antigens in
heterogeneous Asian Indian patients with systemic sclerosis… The individual antibodies titre to …

… To avoid off-target effect, we used IL4Rα neutralizing antibody to block IL4 signaling and
found decreased expression of p-mTOR and elevated expression of RUNX2 in Fbn1 +/− …

… patients with systemic sclerosis (SSc), 10 systemic vasculitides, 8 and systemic lupus …
Anti–lipoprotein lipase antibodies have been associated with elevated levels of triglycerides and …

Systemic sclerosis (SSc), an autoimmune disease, may cause significant osteopenia due to
activation of the IL4Rα/mTOR pathway. Mesenchymal stem cell transplantation (MSCT) can …